litlas
Log inCreate account

Giuseppe Giaccone

Active 1986–2025

260
Papers
61,039
Citations
128
h-index
260
i10-index

Citations

Citations per year for Giuseppe Giaccone1971: 1 citations1988: 2 citations1989: 1 citations1990: 4 citations1991: 6 citations1992: 11 citations1993: 11 citations1994: 11 citations1995: 11 citations1996: 29 citations1997: 38 citations1998: 46 citations1999: 73 citations2000: 72 citations2001: 89 citations2002: 156 citations2003: 209 citations2004: 313 citations2005: 450 citations2006: 409 citations2007: 371 citations2008: 346 citations2009: 376 citations2010: 391 citations2011: 487 citations2012: 446 citations2013: 510 citations2014: 436 citations2015: 489 citations2016: 531 citations2017: 482 citations2018: 483 citations2019: 1,586 citations2020: 1,746 citations2021: 1,674 citations2022: 1,278 citations2023: 942 citations2024: 1,461 citations2025: 609 citations2026: 15 citations1972–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,118 citing papers, 23.9% of this breakdownChina: 3,046 citing papers, 14.2% of this breakdownItaly: 1,191 citing papers, 5.6% of this breakdownUnited Kingdom: 1,187 citing papers, 5.5% of this breakdownJapan: 1,100 citing papers, 5.1% of this breakdownGermany: 907 citing papers, 4.2% of this breakdownFrance: 815 citing papers, 3.8% of this breakdownNetherlands: 717 citing papers, 3.4% of this breakdownSpain: 693 citing papers, 3.2% of this breakdownCanada: 688 citing papers, 3.2% of this breakdownSouth Korea: 570 citing papers, 2.7% of this breakdownAustralia: 469 citing papers, 2.2% of this breakdown
0%23.9%Other 23%

Institutions

Fields

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology26.1%
  • Immunology and Microbiology4.8%
  • Engineering0.9%
  • Computer Science0.7%
  • Materials Science0.6%
  • Other2.9%

Topics

  • Lung Cancer Treatments and Mutations9.8%
  • Lung Cancer Diagnosis and Treatment5.8%
  • Lung Cancer Research Studies5.4%
  • Cancer Immunotherapy and Biomarkers4.6%
  • Cancer Genomics and Diagnostics2.4%
  • HER2/EGFR in Cancer Research2%
  • Other70%

Coauthors

All papers

Open in search
  1. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

    Authors: Peter Goldstraw, Kari Chansky, John Crowley, Ramón Rami–Porta, Hisao Asamura, Wilfried Eberhardt, Andrew G. Nicholson, Patti A. Groome, Alan Mitchell, Vanessa Bolejack, Peter Goldstraw, Ramón Rami–Porta, Hisao Asamura, David Ball, David G. Beer, Ricardo Beyruti, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Eberhardt, John Edwards, Françoise Galateau-Sallé, Dorothy J. Giroux, Fergus Gleeson, Patti A. Groome, James Huang, Catherine Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, R. Guijarro Jorge, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M.A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, I. Macía Vidueira, E. Fernández Araujo, Felipe Andreo García, Kwun M. Fong, Gloria Francisco Corral and 52 more - Journal of Thoracic Oncology 2016 cited by 4,643

  2. Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

    Authors: Roy S. Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, A. Vergnenègre, Carlos H. Barrios, Masahiro Morise, Enriqueta Felip, Zoran Andrić, Sarayut Lucien Geater, Mustafa Özgüroğlu, Wei Zou, Alan Sandler, Ida Enquist, Kimberly M. Komatsubara, Yu Deng, Hiroshi Kuriki, Xiaohui Wen, Mark L. McCleland, Simonetta Mocci, Jacek Jassem, David R. Spigel - New England Journal of Medicine 2020 cited by 1,691

  3. Targeting the dynamic HSP90 complex in cancer

    Authors: Jane B. Trepel, Mehdi Mollapour, Giuseppe Giaccone, Len Neckers - Nature reviews. Cancer 2010 cited by 1,528

  4. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Authors: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 cited by 1,744

  5. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

    Authors: William D. Travis, Hisao Asamura, Alexander A. Bankier, Mary Beth Beasley, Frank Detterbeck, Douglas B. Flieder, Jin Mo Goo, Heber MacMahon, David P. Naidich, Andrew G. Nicholson, Charles A. Powell, Mathias Prokop, Ramón Rami–Porta, Valerie W. Rusch, Paul Van Schil, Yasushi Yatabe, Peter Goldstraw, Ramón Rami–Porta, Hisao Asamura, David Ball, David G. Beer, Ricardo Beyruti, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Eberhardt, John Edwards, Françoise Galateau-Sallé, Dorothy J. Giroux, Fergus Gleeson, Patti A. Groome, James Huang, Catherine Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone - Journal of Thoracic Oncology 2016 cited by 728

  6. Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

    Authors: Jacek Jassem, Filippo de Marinis, Giuseppe Giaccone, A. Vergnenègre, Carlos H. Barrios, Masahiro Morise, Enriqueta Felip, Cristina Oprean, Young‐Chul Kim, Zoran Andrić, Simonetta Mocci, Ida Enquist, Kimberly M. Komatsubara, Mark L. McCleland, Hiroshi Kuriki, Monette Villalobos, See Phan, David R. Spigel, Roy S. Herbst - Journal of Thoracic Oncology 2021 cited by 202

  7. Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

    Authors: Charles M. Rudin, Christine L. Hann, Edward B. Garon, Moacyr Oliveira, Philip Bonomi, D. Ross Camidge, Quincy S. Chu, Giuseppe Giaccone, Divis Khaira, Suresh S. Ramalingam, Malcolm Ranson, Caroline Dive, Evelyn McKeegan, Brenda Chyla, Barry L. Dowell, Arunava Chakravartty, Cathy E. Nolan, Niki S. Rudersdorf, Todd Busman, Mack Mabry, Andrew Krivoshik, Rod Humerickhouse, Geoffrey I. Shapiro, Leena Gandhi - Clinical Cancer Research 2012 cited by 551

  8. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

    Authors: Kari Chansky, Frank Detterbeck, Andrew G. Nicholson, Valerie W. Rusch, Eric Vallières, Patti A. Groome, Catherine J. Kennedy, Mark Krasnik, Michael Peake, Lynn Shemanski, Vanessa Bolejack, John J. Crowley, Hisao Asamura, Ramón Rami–Porta, Peter Goldstraw, Ramón Rami–Porta, Hisao Asamura, David Ball, David G. Beer, Ricardo Beyruti, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Eberhardt, John Edwards, Françoise Galateau-Sallé, Dorothy J. Giroux, Fergus Gleeson, Patti A. Groome, James Huang, Catherine J. Kennedy, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, R. Guijarro Jorge, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M. A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, I. Macía Vidueira and 56 more - Journal of Thoracic Oncology 2017 cited by 507

  9. A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

    Authors: Giuseppe Giaccone, Lyudmila Bazhenova, John Nemunaitis, Ming Tan, Erzsébet Juhász, Rodryg Ramlau, Michel M. van den Heuvel, Rohit Lal, Goetz Kloecker, Keith D. Eaton, Quincy S. Chu, David J. Dunlop, Minish Jain, Edward B. Garon, Ch Davis, Ewa Carrier, Steven Moses, Daniel L. Shawler, Habib Fakhrai - European Journal of Cancer 2015 cited by 272

  10. Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

    Authors: Mark G. Kris, D. Ross Camidge, Giuseppe Giaccone, Toyoaki Hida, Bob T. Li, Joseph O’Connell, Ian W. Taylor, H. Zhang, Maria E. Arcila, Zelanna Goldberg, Pasi A. Jänne - Annals of Oncology 2015 cited by 332

  11. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

    Authors: Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo, Céline Mascaux, Anne Madroszyk, Federico Cappuzzo, Werner Hilgers, Gianpiero Romano, Fabrice Denis, Santiago Viteri, D. Debieuvre, Domenico Galetta, Editta Baldini, M. Razaq, G. Robinet, Michele Maio, Angelo Delmonte, Benoît Roch, Patrick Masson, Wolfgang Schuette, Alona Zer, Jordi Remón, D Costantini, B. Vasseur, Rafał Dziadziuszko, Giuseppe Giaccone, Milada Zemanová, Benjamin Besse, Clément Bonnet, Jacques Cadranel, C. Chouaïd, Alexis B. Cortot, D. Debieuvre, B. Delclaux, Fabrice Denis, Boris Duchemann, Claude El Kouri, François‐Régis Ferrand, M. Ginoux, Werner Hilgers, Anne Madroszyk, Patrick Masson, Julien Mazières, O. Molinier, Denis Moro‐Sibilot, Éric Pichon, Céline Mascaux, G. Robinet, Benoît Roch, Gérard Zalcman, Gerlinde Schmidtke-Schrezenmeier, Wolfgang Schuette, László Urbán, Maya Gottfried, Hovav Nechushtan, Nir Peled, M. Wollner, Alona Zer, Editta Baldini, Laura Bonanno, Andrea Bonetti, Federico Cappuzzo, Angelo Delmonte, Domenico Galetta, Michele Maio, V. Minotti, Antonio Rea, Gianpiero Romano, Davide Tassinari, Giuseppe Tonini, Rafał Dziadziuszko, Bogusława Karaszewska, Aleksandra Szczęsna, Manuel Cobo, J. De Castro, Enriqueta Felip, M.R. García Campelo, Ainhoa Hernández, Teresa Morán, Mariano Provencio, Santiago Viteri, Abhijit Dasgupta, Nashat Gabrail, Giuseppe Giaccone, A. Harshad, Stephen V. Liu, D. Oubre, Rajiv Panikkar, M. Razaq, Rachel E. Sanborn - Annals of Oncology 2023 cited by 70

  12. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Authors: Andrew G. Nicholson, Kari Chansky, John Crowley, John Crowley, Kaoru Kubota, Andrew T. Turrisi, Wilfried Eberhardt, Jan P. van Meerbeeck, Ramón Rami–Porta, Peter Goldstraw, Ramón Rami–Porta, Hisao Asamura, David Ball, David G. Beer, David G. Beer, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Eberhardt, John Edwards, Françoise Galateau-Sallé, Dorothy J. Giroux, Fergus Gleeson, Patti A. Groome, James Huang, Catherine J. Kennedy, Catherine Kennedy, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Kaoru Kubota, Gustavo Lyons, Mirella Marino, Edith M. Marom, Jan P. van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G. Nicholson, Anna K. Nowak, Michael Peake, Thomas W. Rice, Kenneth E. Rosenzweig, Enrico Ruffini, Valerie W. Rusch, Nagahiro Saijo, Paul Van Schil, Jean‐Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F. Thomas, William D. Travis, Ming‐Sound Tsao, Andrew T. Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi‐Long Wu, Hirokazu Watanabe, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp H. Kernstine, Hedy L. Kindler, Lee M. Krug, Kristiaan Nackaerts, Harvey I. Pass, David C. Rice, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene H. Blackstone, F. Abad Cavaco, Emilio Ansótegui Barrera, J. Abal Arca, Isaura Parente Lamelas, A. Arnau Obrer, I. Parente Lamelas, David Ball, G.K. Bascom, Ana Isabel Blanco Orozco, M.A. González Castro, Matthew G. Blum, Domingo Chimondeguy, Vlado Cvijanović, Sebastián Defranchi, B. de Olaiz Navarro, I. Escobar Campuzano, B. de Olaiz Navarro, E. Fernández Araujo, F. Andreo García, Kwun M. Fong, Gloria Francisco Corral, S. Cerezo González and 52 more - Journal of Thoracic Oncology 2015 cited by 424

  13. Classification of current anticancer immunotherapies

    Authors: Lorenzo Galluzzi, Erika Vacchelli, José Manuel Bravo‐San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean‐Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa M. Coussens, Madhav V. Dhodapkar, Alexander Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek D. Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Paweł Kaliński, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, J P Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J.M. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, A. Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer A. Rizvi, Catherine Sautès‐Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva‐Santos, Mark J. Smyth, Daniel E. Speiser, Radek Špíšek, Pramod K. Srivastava, James E. Talmadge, Éric Tartour, Sjoerd H. van der Burg, Benoı̂t J. Van den Eynde, Richard G. Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou, Guido Kroemer - Oncotarget 2014 cited by 470

  14. Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

    Authors: Fabio Conforti, Laura Pala, Eleonora Pagan, Vincenzo Bagnardi, Tommaso De Pas, Paola Queirolo, Elisabetta Pennacchioli, Chiara Catania, Emilia Cocorocchio, Pier Francesco Ferrucci, Maristella Saponara, Gianmarco Orsolini, Paola Zagami, Eleonora Nicolò, Filippo de Marinis, Giampaolo Tortora, Emilio Bria, Saverio Minucci, Hadine Joffe, Paolo Veronesi, Jennifer A. Wargo, Rachel Rosenthal, Charles Swanton, Alberto Mantovani, Richard D. Gelber, Giuseppe Viale, Aron Goldhirsch, Giuseppe Giaccone - Clinical Cancer Research 2021 cited by 103

  15. Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

    Authors: Giuseppe Giaccone, Chul Kim, Jillian Thompson, Colleen McGuire, Bhaskar Kallakury, Joeffrey Chahine, Maria A. Manning, Robin Mogg, Wendy M. Blumenschein, Ming Tan, Deepa S. Subramaniam, Stephen V. Liu, Ian M. Kaplan, Justine N. McCutcheon - The Lancet Oncology 2018 cited by 400

  16. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH

    Authors: Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Anna Kasprzyk-Pawelec, Shreyas M. Gadre, Erika Parasido, Olga Catalina-Rodriguez, Patricia L. Foley, Giuseppe Giaccone, Amrita K. Cheema, Bhaskar Kallakury, Chris Albanese, Chunling Yi, Maria Laura Avantaggiati - Cell Death and Differentiation 2020 cited by 133

  17. Advancements in small cell lung cancer

    Authors: Jung-Hoon Lee, Ashish Saxena, Giuseppe Giaccone - Seminars in Cancer Biology 2023 cited by 81

  18. The Integrated Genomic Landscape of Thymic Epithelial Tumors

    Authors: Milan Radovich, Curtis R. Pickering, Ina Felau, Gavin Ha, Hailei Zhang, Heejoon Jo, Katherine A. Hoadley, Pavana Anur, Jiexin Zhang, Mike McLellan, Reanne Bowlby, Thomas Matthew, Ludmila Danilova, Apurva M. Hegde, Jaegil Kim, Mark D.M. Leiserson, Geetika Sethi, Charles Lu, Michael Ryan, Xiaoping Su, Andrew D. Cherniack, Gordon Robertson, Rehan Akbani, Paul T. Spellman, John N. Weinstein, D. Neil Hayes, Benjamin J. Raphael, Tara M. Lichtenberg, Kristen Leraas, Jean C. Zenklusen, Junya Fujimoto, Cristovam Scapulatempo‐Neto, André L. Moreira, David Hwang, James Huang, Mirella Marino, Robert J. Korst, Giuseppe Giaccone, Yesim Gökmen‐Polar, Sunil Badve, Arun Rajan, Philipp Ströbel, Nicolas Girard, Ming‐Sound Tsao, Alexander Marx, Anne S. Tsao, Patrick J. Loehrer, Adrian Ally, Elizabeth L. Appelbaum, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Madhusmita Behera, Rameen Beroukhim, Mario Berríos, Giovanni Blandino, Tom Bodenheimer, Moiz S. Bootwalla, Jay Bowen, Denise Brooks, Flavio Mavignier Cárcano, Rebecca Carlsen, André Lopes Carvalho, Patricia Castro, Lara Chalabreysse, Lynda Chin, Juok Cho, Gina Choe, Eric Chuah, Sudha Chudamani, Carrie Cibulskis, Leslie Cope, Matthew G. Cordes, Daniel Crain, Erin Curley, Timothy Defreitas, John A. Demchok, Frank Detterbeck, Noreen Dhalla, Hendrik Dienemann, W. Jeff Edenfield, Francesco Facciolo, Martin L. Ferguson, Scott Frazer, Catrina C. Fronick, Lucinda A. Fulton, Robert S. Fulton, Stacey Gabriel, Johanna Gardner, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, David I. Heiman, Shital Hobensack, Andrea Holbrook, Robert A. Holt, Alan P. Hoyle, Carolyn M. Hutter, Michael Ittmann and 88 more - Cancer Cell 2018 cited by 383

  19. Sex and cancer immunotherapy: Current understanding and challenges

    Authors: Laura Pala, Tommaso De Pas, Chiara Catania, Giuseppe Giaccone, Alberto Mantovani, Saverio Minucci, Giuseppe Viale, Richard D. Gelber, Fabio Conforti - Cancer Cell 2022 cited by 65

  20. First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

    Authors: Yung‐Jue Bang, Giuseppe Giaccone, S.-A. Im, Do‐Youn Oh, Todd M. Bauer, Jeffrey L. Nordstrom, H. Li, Gurunadh R. Chichili, Paul A. Moore, Soo-Hwa Hong, Samantha Stewart, Jan Baughman, Robert J. Lechleider, Howard A. Burris - Annals of Oncology 2017 cited by 225

  21. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: Nasser H. Hanna, David H. Johnson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Thomas J. Smith, Joan Tashbar, William A. Biermann, Gregory A. Masters - Journal of Clinical Oncology 2017 cited by 650

  22. A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

    Authors: Bernard M. Tijink, Jan Buter, Remco de Bree, Giuseppe Giaccone, Margreet Lang, Alexander Staab, C. René Leemans, Guus A.M.S. van Dongen - Clinical Cancer Research 2006 cited by 316

  23. Update on Hsp90 Inhibitors in Clinical Trial

    Authors: Yoonhee Kim, S. Alarcon, S. Lee, M.-J. Lee, Giuseppe Giaccone, Len Neckers, Jane B. Trepel - Current Topics in Medicinal Chemistry 2009 cited by 307

  24. Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

    Authors: Chul Kim, Stephen V. Liu, Deepa S. Subramaniam, Tisdrey Torres, Massimo Loda, Giuseppe Esposito, Giuseppe Giaccone - Journal for ImmunoTherapy of Cancer 2020 cited by 85